GB1128705A - Dissolution of mucous secretions - Google Patents

Dissolution of mucous secretions

Info

Publication number
GB1128705A
GB1128705A GB2501/67A GB250167A GB1128705A GB 1128705 A GB1128705 A GB 1128705A GB 2501/67 A GB2501/67 A GB 2501/67A GB 250167 A GB250167 A GB 250167A GB 1128705 A GB1128705 A GB 1128705A
Authority
GB
United Kingdom
Prior art keywords
jan
dispersing
solution
dissolving
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2501/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of GB1128705A publication Critical patent/GB1128705A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB2501/67A 1966-01-18 1967-01-17 Dissolution of mucous secretions Expired GB1128705A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA950136 1966-01-18

Publications (1)

Publication Number Publication Date
GB1128705A true GB1128705A (en) 1968-10-02

Family

ID=4142430

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2501/67A Expired GB1128705A (en) 1966-01-18 1967-01-17 Dissolution of mucous secretions

Country Status (5)

Country Link
BE (1) BE692834A (cs)
CA (1) CA892543A (cs)
FR (1) FR6370M (cs)
GB (1) GB1128705A (cs)
NL (1) NL6700744A (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070173A1 (en) * 1969-10-29 1971-09-10 Alcon Lab In Stabilized aqs pyrocatecholamine prepns
GB2198942A (en) * 1985-11-27 1988-06-29 Senju Pharma Co Therapeutic composition for diabetic complications

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070173A1 (en) * 1969-10-29 1971-09-10 Alcon Lab In Stabilized aqs pyrocatecholamine prepns
GB2198942A (en) * 1985-11-27 1988-06-29 Senju Pharma Co Therapeutic composition for diabetic complications
GB2198942B (en) * 1985-11-27 1990-07-11 Senju Pharma Co Therapeutic composition for diabetic complications

Also Published As

Publication number Publication date
CA892543A (en) 1972-02-08
NL6700744A (cs) 1967-07-19
FR6370M (cs) 1968-10-14
BE692834A (cs) 1967-07-03

Similar Documents

Publication Publication Date Title
HK28984A (en) Composition and method for combating virus infections
SE8402550D0 (sv) N-substituerade deriavat av moranolin
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
EP0706373A4 (en) TAXOL ENCLOSED IN LIPOSOMES AND METHOD OF USE
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
BR9912375A (pt) Sais de nitrato, composições farmacêuticas, uso de sais e composições, e, processo para preparação de sais de nitrato.
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
GB1128705A (en) Dissolution of mucous secretions
ATE33759T1 (de) Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle.
ES386308A1 (es) Un procedimiento para la preparacion de productos a base demetobromuro de n-iropropil-noratropinio.
ES450299A1 (es) Un procedimiento de fabricacion de nuevos compuestos quimi- cos derivados de n-pinolidin-2-etilamina.
RU93051046A (ru) Способ борьбы с аскосферозом и гнильцовыми болезнями пчел
IE34728L (en) Treatment of migraine
GB922662A (en) Improvements in or relating to aqueous isoprenaline compositions
EP0010515A3 (en) (n-methylcarbamoyl-phenoxy)-(n&#39;.n&#34;.n&#34;-trialkyl urea)-n.n&#39;-sulfide derivatives, process for their preparation, compositions containing these derivatives as active components and their use in combating insects; (n-methyl-carbamoylhalogenide)-(n&#39;.n&#34;.n&#39;&#34;-trialkyl urea)-n.n&#39; sulfides and process for their preparation
GB1430726A (en) Pharmaceutical preparations containing resorcinol deirvatives
TH13510A (th) ระบบนำส่งยาเฉพาะที่ที่ดีขึ้นซึ่งแทรกซึมผ่านผิวหนังได้เพิ่มขึ้น